Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
US4525300A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Sep 23, 1983 |
| Grant date | Jun 25, 1985 |
| Priority date | — |
| Expiry date | Sep 23, 2003 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/221
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
An antibody of a human leukemia virus-related peptide obtained by collecting an antibody produced in a mammal body by administering to the mammal an antigen prepared by reacting a human leukemia virus-related peptide selected from the group consisting of: PA0 (a) a peptide represented by formula (1): EQU H-Tyr-Val-Glu-Pro-Thr-Ala-Pro-Gln-Val-Leu-H (1) PA0 (b) a peptide represented by formula (2): EQU R-Ile-Pro-His-Pro-Lys-Asn-Ser-Ile-Gly-Gly-Glu-Val-OH (2) PA0 wherein R is the same as drefined above; PA0 (c) a peptide represented by formula (3): EQU R-Thr-Trp-Thr-Pro-Lys-Asp-Lys-Thr-Lys-Val-Leu-OH (3) PA0 wherein R is the same as defined above; PA0 (d) a peptide represented by formula (4): EQU H-Val-Val-Gln-Pro-Lys-Lys-Pro-Pro-Pro-Tyr-OH (4) PA0 (e) a peptide represented by formula (5): EQU R-Met-Gly-Gln-Ile-Phe-Ser-Arg-Ser-Ala-Ser-Pro-OH (5) PA0 wherein R is the same as defined above; and PA0 (f) a peptide represented by formula (6): EQU H-Tyr-Pro-Glu-Gly-Thr-Pro-Lys-Asp-Pro-Ile-Leu-Arg-Ser-Leu-OH (6) as a hapten, with a carrier in the presence of a hapten-carrier binding agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.